Colossal Biosciences
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1401 Lavaca St Unit 155, Austin, Texas, ...Website
www.colossal.comRevenue
$27.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
4
1
1
About Colossal Biosciences
Colossal Biosciences is a biotechnology company pioneering the field of de-extinction, using advanced genetic engineering and CRISPR technologies to revive extinct species such as the woolly mammoth. The company combines genomics, synthetic biology, and conservation science to develop solutions aimed at biodiversity restoration and ecosystem health. In addition to de-extinction, Colossal builds genomic tools and technologies that can support conservation efforts, prevent species extinction, and advance biological research.Explore more
Colossal Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Colossal Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Colossal Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Colossal Biosciences
Check out if Colossal Biosciences is spiking on competitors!
Colossal Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Colossal Biosciences launches new products
Funding: Get notified immidiatlly once Colossal Biosciences has new funding data
Check if Colossal Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Colossal Biosciences had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Colossal Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Colossal Biosciences
Compare insights from companies similar to Colossal Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Colossal Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Colossal Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Colossal Biosciences.
Colossal Biosciences financials insights
Gather financial insights about Colossal Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$15M
2022
Series A
$75M
Other Financing Round
$10M
2023
Series B
$150M
2025
Series C
$320M
Colossal Biosciences Tech Stack
A closer look at the technologies used by Colossal Biosciences
Most Recent Scoops
Person-Based
Research & Development
Person-Based
Hiring Plans
Colossal Biosciences has more open roles in Engineering & Technical than it has had at any time in the past 9 months. Areas of expertise include: Biology, Assay Development, Molecular Biology, Fluorescent Microscopy, Cross-Functional Collaboration, Cell Biology, and Scientific Studies.
Hiring Plans
Person-Based
Research & Development, Bioengineering
Person-Based
Colossal Biosciences News & Media
Colossal Biosciences Hatches First Chicks from Its Fully Artificial Egg System
The first-ever shell-less incubation system to support complete avian embryo development, enabling next-generation conservation and de-extinction DALLAS, May 19, 2026 /PRNewswire/ -- Colossal Biosciences, the world's first de-extinction company, today announced that it has hatched live...Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck
The project, actively in progress, is powered by world-first breakthroughs in antelope reproduction and stem cell science; supported by local South African conservation organizations to support thoughtful rewilding efforts; and provides new technologies positioned to reverse centuries of...Colossal Launches 2026 Super Mom Competition to Celebrate Everyday Heroes and Support Children's Miracle Network®
One extraordinary mom will win $20,000, a dream family vacation, and a feature in NewBeauty Magazine PHOENIX, March 24, 2026 /PRNewswire/ -- Colossal, a nationally registered professional fundraiser known for its purpose-driven competitions, proudly announces the return of its Super Mom...Templum to Offer Premier Private Market Investment Opportunities in Perplexity AI, OpenAI, and Colossal Biosciences to SoFi Members
Limited-time offering provides investors access to highly sought-after private market leaders NEW YORK, March 5, 2026 /PRNewswire/ -- Templum, a leading infrastructure provider for private markets and SoFi (NASDAQ: SOFI), the one-stop shop for digital financial services, today announced...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Colossal Biosciences
Sign Up For FreeTo access detailed company insights
Colossal Biosciences is a biotechnology company pioneering the field of de-extinction, using advanced genetic engineering and CRISPR technologies to revive extinct species such as the woolly mammoth. The company combines genomics, synthetic biology, and conservation science to develop solutions aimed at biodiversity restoration and ecosystem health... Read More
